Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Rudi Coninx a Unit of Medicine and Community Health Care,
International Committee of the Red Cross, 19 Avenue de la Paix, 1202 Geneva, Switzerland, b Communicable Diseases Prevention and Control, World Health
Organisation, 20 Avenue Appia, 1202 Geneva, Switzerland, c Center for the Study of Society and Medicine, Columbia
University, New York, 10032 NY, USA
Correspondence to: R Coninx rconinx{at}gmx.net
On any day worldwide about 10 million people are
incarcerated, in prisons, remand centres, police stations, jails,
detention centres for asylum seekers, penal colonies, and prisoner of
war camps. There is an increasing recognition that the high risk of tuberculosis in these settings poses a problem for those imprisoned and
for the wider society. The issue now is what to do about what was until
very recently "a forgotten plague."1 The important general measures for tuberculosis control in prisons are improvement of
prison conditions, particularly a reduction in overcrowding, improvement of nutrition and hygiene, and guaranteed access to improved
prison health services.
Knowledge of the epidemiology of tuberculosis in prisons, appreciation
of what makes control different from control in other settings, and
understanding of the principles of tuberculosis control are all
necessary for governmental and other agencies to contribute to the
implementation of effective tuberculosis control programmes in prisons.
We have focused here on countries with a high prevalence of
tuberculosis, where the problem is most severe and the need for
action most pressing, and on the specific measures necessary in the
implementation of an effective prison tuberculosis programme.
The article is based on information from ongoing clinical work,
follow up of ongoing prison programmes, and reports from prisons, supplemented by literature searches.
Prisons are closed institutions for prisoners during their period
of incarceration. They are not, however, closed to the tuberculosis bacillus, and prisoners are often highly mobile, circulating within the
system: inside the prison, between different prisons, between different
institutions of the judiciary system, and between prisons and health
centres. Sooner or later, prisoners are released. Often former
prisoners re-enter the system after new offences. Prison staff and
visitors come and go as well. The prison reservoir thus poses a risk
for society. Effective tuberculosis control in prisons is necessary to
protect the wellbeing of both prisoners and the wider community.
The table shows published tuberculosis case rates in prisons in
countries with a high prevalence. These rates are among the highest
ever recorded in any population. Cases of tuberculosis in prison are
often not routinely reported as it is usually the ministry of justice
or interior that is responsible for reporting prison health data. These
data rarely find their way into the ministry of health statistics,
which are used for international reporting and for policy decisions.
For example, in Azerbaijan the estimated number of cases of
tuberculosis in prison in 1995 was 700, but only 1429 cases (excluding
these 700) were reported to the World Health
Organisation.8 In some countries the number of
tuberculosis cases in prisons constitutes a large proportion of the
total number of cases. It is estimated that there will be about 75 000
new cases annually in the Russian civilian population (for a population
of 150 million), while in Russian prisons there will be 40 000 new
cases for a population of 1 million. Thus more than half the number of
new tuberculosis cases will occur in prison. 9
Prison society is different from civil society, and this has
implications for tuberculosis programmes. Prisoners do not represent a
cross section of society, a high proportion is poorly educated and
socioeconomically disadvantaged. They therefore bring with them into
prison an increased risk of ill health, including a high risk of
tuberculosis infection and disease. Prison life is not conducive to
good health. Overcrowding and prolonged exposure through long prison
sentences (even for seemingly minor offences) promote
tuberculosis.
10 11
Illegal drug use, although forbidden, is common, and injecting equipment is used in primitive and unhygienic conditions. Sex between men, voluntary or forced, occurs, and use of
condoms is rare. The HIV epidemic further complicates control of
tuberculosis in prisons. Prison conditions, tuberculosis, and HIV
transmission are thus interconnected.
Summary points
People incarcerated are at high risk for tuberculosis and case
rates are among the highest ever recorded in any population
The specific features of prisons and of prisoners necessitate specific
approaches to tuberculosis control that are different from those used
in the general population
Guarantees are needed to ensure completion of treatment; and this
requires political and administrative commitment
Prisons can also provide an opportunity for effective tuberculosis
control, which may well lead to improved prison health care
![]()
Methods
![]()
Epidemiology of tuberculosis in prisons
![]()
Why prisons are different?

(Credit: IVAN SEKRETAREV/AP PHOTO)
Inmates at tuberculosis prison in Tula, Russia
The mobility of prisoners within the system and between prisons and the
wider community often makes it difficult for authorities to ensure
prisoners with tuberculosis complete their treatment. The ministry
responsible for health care in prisons is usually not the ministry of
health
for example, the ministry of justice or the ministry of
interior. These ministries have different priorities and often less
experience and less skill in providing health care. People working in
prison administration, who are responsible for providing health
services, are commonly underpaid and the departments understaffed,
resulting in poor health services available only for those who pay.
Prison health services often fail to implement effective tuberculosis
control and guarantee cure of tuberculosis, and prisoners are at high
risk of leaving prison with the disease. Delayed diagnosis and
substandard treatment are common, resulting in prolonged transmission.
The combination of incomplete, interrupted, and inadequate treatment
often leads to drug resistance; the combination of delayed diagnosis,
insufficient treatment, and drug resistance results in high case fatality.
Prisoners lose their freedom as punishment, but they also lose free
choice in many other matters and especially concerning their health.
Often an unofficial internal hierarchy exists within the prison
population. The power structures in the prisons of the republics of the
former Soviet Union, for example, resemble a caste system and have been
described previously.12 Other different hierarchical
systems are always part of the prison "subculture." It is important
to be aware of the existence of these systems as they may interfere
with medical administrative decisions
for example, there may be
discrimination in admission to the hospital ward and unfair selection
of prisoners for treatment. Internal hierarchical rules may also result
in higher caste inmates denying lower caste room mates access to health
services or forcing them to hoard medicines for later use. In other
countries, structures of politically motivated groups may remain intact
in the prison system, and groups may actually collaborate with the
health staff. Hierarchy may also be based on ethnic or religious
affiliation. Prisons are always violent societies, and unofficial rules
are imposed by force if necessary, with underdog prisoners always losing in the end.
Where antituberculosis drugs are scarce a black market may develop, controlled by the more influential prisoners. Prisoners may use tricks and bribery to get into the treatment centres and treat themselves if no treatment is available officially. Prisoners may trade antituberculosis drugs, to be saved for later use or to be traded for goods or services or to pay off debts. Even well informed prisoners may choose to discontinue treatment on account of the lack of a supportive environment and fears that the evidence of active tuberculosis may hinder their release. Organisations working in prisons must be aware that prisoners may exchange or purchase samples known to give positive or negative results on smear tests to join a tuberculosis treatment programme or to leave one (for example, to avoid isolation as a non-responder).
The possible consequences of poor tuberculosis control are disastrous
in a country with poor resources if the prison reservoir of
tuberculosis leads to an epidemic of multidrug resistant disease in the
civilian population. This may already be the case in the republics of
the former Soviet Union, which now face difficult choices.13 Therefore it is crucial that every agency
involved in tuberculosis control in prisons must examine the specific
features that make control different from that in other settings.
| |
Implementing tuberculosis control programmes in prisons |
|---|
In response to the needs of governmental and other agencies that are dealing with this problem in countries with a high prevalence of tuberculosis, the World Health Organisation and the International Committee of the Red Cross have joined forces to produce guidelines for the control of tuberculosis in prisons and similar institutions.14 The internationally recommended strategy for tuberculosis control relies on the detection and cure of patients, with a priority for infectious cases.15 Although dependent on the availability of resources, screening of prisoners on entry into prison may have a role in early case detection. The specific features of prisons and prisoners necessitate specific approaches to the implementation of this strategy. For example, direct observation is necessary, not only of treatment to ensure adherence and prevent entry of drugs on to the black market but also when prisoners submit sputum samples because of the trade in these samples.
Political and administrative commitment are vital for success. The ability to ensure completion of treatment is a prerequisite in the establishment of an effective prison control programme. In those countries with an effective national tuberculosis programme, close liaison between the prisons and the programme is necessary to ensure that prisoners with tuberculosis complete treatment after release. In those countries without an effective programme a new or revised prison programme should treat only those prisoners with tuberculosis whose prison sentence is longer than the duration of tuberculosis treatment. This should be an intermediary step until the establishment of an effective national programme.
Commitment to ensuring completion of treatment implies special considerations for those prisoners who are awaiting charge, trial, or sentence. The period of detention in remand custody is unpredictable but is often too short for the completion of tuberculosis treatment. Authorities must ensure completion of treatment of these prisoners whether they are released or sentenced to prison. The authorities responsible for prisoners awaiting sentence therefore need to develop close links with both the health authorities in the community and the prison health authorities. Ensuring completion of treatment of prisoners awaiting sentence is crucial, otherwise the custodial system of such prisoners will be a source of transmission of tuberculosis in prisons and the wider community.
Ensuring completion of treatment also implies special considerations for prisoners transferred within a prison or between prisons. The administration of a tuberculosis control programme is more straightforward when a patient starts and completes treatment at the same centre. Prison authorities should ensure that a patient completes at least the initial phase of treatment without transfer between prisons. When a patient in the continuation phase of treatment transfers to another prison, the prison authorities must ensure completion of treatment in the other prison.
Agencies seeking to help in this unprecedented crisis must work closely
with governments and coordinate their efforts with other agencies. They
need to obtain detailed and written agreements on tasks,
responsibilities, and policies. Recognition of the key coordinating
role of the national tuberculosis programmes is crucial.
| |
Prisons as an opportunity for effective tuberculosis control |
|---|
Certain features of the prison environment make tuberculosis control difficult, but other features may provide an opportunity to implement effective control programmes. For example, the captive audience in prisons should facilitate direct observation of treatment, complete coverage, and health education. A well run prison tuberculosis programme may lead to the establishment of an effective national programme, especially in countries where traditional approaches to tuberculosis control run counter to the current international recommendations. This is often the case in the republics of the former Soviet Union.
Effective tuberculosis control in prisons may lead to an improved
prison healthcare system by providing the stimulus to raise the profile
of prison health care, allocate more funds, and improve coordination
between the different ministries and agencies involved. Prison
potentially provides an opportunity to provide health care to a group
often previously without access to such care, who are at increased risk
of illness. The recent surge in interest in tuberculosis control in
prisons provides an opportunity for all involved to join forces in
tackling this epidemic.
| |
Footnotes |
|---|
Funding: None.
Competing interests: None declared.
| |
References |
|---|
| 1. |
Drobniewski F.
Tuberculosis in prisons forgotten plague.
Lancet
1995;
345:
948-949.
|
| 2. | Wares DF, Clowes CI. Tuberculosis in Russia. Lancet 1997; 350: 957[Medline]. |
| 3. | Coninx R, Eshaya-Chauvin B, Reyes H. Tuberculosis in prisons. Lancet 1995; 346: 1238-1239[Medline]. |
| 4. | Aerts A. Prevalence of infectious tuberculosis in the prison population of Georgia. Int J Tuberculosis Lung Dis 1998; 2(suppl 2): S193. |
| 5. | Koffi N, Ngom AK, Aka-Danguy E, Seka A, Akoto A, Fadiga Dl. Smear positive pulmonary tuberculosis in a prison setting: experience in the penal camp of Bouake, Ivory Coast. Int J Tuberculosis Lung Dis 1997; 3: 250-253. |
| 6. | Auregan G, Rakotomanana F, Ratsitorahina M, Rakotoniaina N, Rabemananjara O, Raharimanan R, et al. La tuberculose en milieu carcéral a Atananarivo de 1990 à 1993. Arch Inst Pasteur Madagascar 1995; 62(1): 18-23[Medline]. |
| 7. | Nyangulu DS, Harries AD, Kang'ombe C, Yadidi AE, Chikani K, Cullinan T, et al. Tuberculosis in a prison population in Malawi. Lancet 1997; 350: 1284-1287[CrossRef][Medline]. |
| 8. | World Health Organisation. Global tuberculosis programme. Global tuberculosis control. Geneva: World Health Organisation, 1997. (WHO/TB/97.225:66.) |
| 9. | Goldfarb A, Kimerling ME. Public Health Research Institute/Soros Foundation interim report on the Russian TB program. New York: Public Health Research Institute, 1999. |
| 10. | MacIntyre CR, Kendig N, Kummer L, Birago S, Graham NMH. Impact of tuberculosis control measures and crowding on the incidence of tuberculous infection in Maryland prisons. Clin Infect Dis 1997; 24: 1060-1067[Medline]. |
| 11. | Bellin EY, Fletcher DD, Safyer SM. Association of tuberculosis infection with increased time in or admission to the New York City jail system. JAMA 1993; 269: 2228-2231[Abstract]. |
| 12. |
Reyes H, Coninx R.
Pitfalls of tuberculosis programmes in prisons.
BMJ
1997;
315:
1447-1450 |
| 13. |
Pablos-Méndez A, Raviglione MC, Laslo A, Binkin N, Rieder H, Bustreo F, et al.
Global surveillance for antituberculosis-drug resistance, 1994-1997.
N Engl J Med
1998;
338:
1641-1649 |
| 14. | Maher D, Grzemska M, Coninx R, Reyes H. Guidelines for the control of tuberculosis in prisons. Geneva: World Health Organisation, 1998. (WHO/TB/98.250.) |
| 15. | Maher D, Chaulet P, Spinaci S, Harries A. Treatment of tuberculosis: guidelines for national programmes. 2nd ed. Geneva: World Health Organisation, 1997. (WHO/TB/97.270.) |
(Accepted 15 October 1999)
Read all Rapid Responses
What can you learn from this BMJ paper? Read Leanne Tite's Paper+